Preference for peptide-based medications is responsible for the increased peptide therapeutics contract API manufacturing market demand. Moreover, various technological advancements are being adopted to facilitate faster and more efficient APIs. The bigger size of peptides helps them in delivering better intracellular effects, thereby proving themselves as better binders to receptors on cell surface.
Companies operating in the peptide therapeutics contract API manufacturing market are expanding their production capabilities in the wake of growing demand for peptide therapeutics to address the increasing number of cancer infections worldwide. They are also collaborating with cancer hospitals to create awareness regarding the same.
Contract API manufacturing is referred to as the outsourcing of manufacturing of active pharmaceutical ingredients (APIs), i.e. the components producing intended effects for a third-party organization.
Outsourcing the API production to a contract manufacturing organization (CMO) helps the pharmaceutical companies in reducing their overheads. CMOs often manufacture APIs in a more cost-effective manner as their sole focus is on production efficiency.
Additionally, outsourcing API manufacturing lets pharmaceutical companies emphasize their core competencies such as drug discovery as well as development. This, in turn, results in increased innovation and productivity.
CMOs are well-versed with navigating complex regulatory landscape of API manufacturing. They can ascertain that manufacturing of API is compliant with relevant regulations, which include Good Manufacturing Practices (GMP).
Rise in preference for peptide-based therapeutics is driving more number of pharma companies to outsource their API manufacturing.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
Peptide-based therapeutics serve as growth factors, hormones, neurotransmitters, anti-infective agents, or ion channel ligands. They function by getting bound to receptors on cell surface and expedite intracellular effects with specificity and higher affinity along with action mode analogous to biologics such as antibodies and therapeutic proteins.
Peptide-based treatments demonstrate lower immunogenicity and are less costly. The physicochemical properties of peptide therapeutics facilitate their preference over the small molecule drugs as an outcome of more flexible backbone, bigger size, which let them behave as stronger inhibitors of protein-to-protein interactions. They are also safer due to lower toxicity.
Peptide therapeutics can be applied to chronic diseases such as cancer in four ways; viz using radioisotopes, as probes or dyes for diagnosis of tumor and imaging, using peptide-coupled nanomaterials for tumor therapeutics, using peptide alone for developing drugs, and using peptide vaccines for activating immune system.
Increasing preference for peptide therapeutics is thus contributing to the peptide therapeutics contract API manufacturing market growth.
Various advanced technologies are being adopted to synthesize peptides for catering to a wider consumer base. Solid-phase synthesis is one amongst the successful methods to synthesize a broad spectrum of peptides, right from short to long sequences.
The scientists are using a method called mass spectrometry for identifying proteins. The ‘bottom-up approach’ is a common mass spectrometry approach, in which full-length proteins are cut into peptides, which are measured using mass spectrometer.
Microflow technology is increasingly used, which facilitates usage of highly unstable and active chemical species or high-temperature conditions that expedite peptide synthesis. The latest developments in this regard include combined use of automated synthesis, microflow technology, and online monitoring technologies to improve efficiency.
Continuous adoption of advanced technologies is thus expanding peptide therapeutics contract API manufacturing market size.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the latest peptide therapeutics contract API manufacturing market analysis, North America dominated the peptide therapeutics API manufacturing services industry in 2023 and the dominance is expected to continue during the forecast period.
This is attributed to the U.S. witnessing a higher demand for peptide therapeutics in the wake of rising awareness regarding the advantages associated with them.
Asia Pacific is also holding a noticeable peptide therapeutics contract API manufacturing market share. This is due to India and China witnessing an influx of clinical trials regarding the use of protein peptides to treat various ailments.
The prominent players in the contract manufacturing of peptide therapeutics APIs landscape are involved in inorganic modes of expansion to make a mark in the contract peptide API synthesis industry.
For instance, in October 2023, PolyPeptide inked a partnership agreement with Peptide Sciences Laboratory of University of KwaZulu-Natal with the objective of receiving scientific support for the former’s projects pertaining to solid phase peptide synthesis.
Ambiopharm Inc, Auspep, Bachem Holding AG, BCN Peptides, Chinese Peptide Company, CordenPharma, CPC Scientific, Creative Peptides, CSBio, Hybio Pharmaceutical, Peptide Institute, Inc., PolyPeptide Group, ScinoPharm, and Senn Chemicals AG are some of the key players covered in the peptide therapeutics contract API manufacturing market report.
These companies have been profiled based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2023 | US$ 2.5 Bn |
| Market Forecast (Value) in 2034 | US$ 5.2 Bn |
| Growth Rate (CAGR) | 6.8% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 2.5 Bn in 2023
It is projected to grow at a CAGR of 6.8% from 2024 to 2034
Preference for peptide-based therapeutics and adoption of advanced technologies for synthesis of peptides
Large enterprise segment accounted for the largest share in 2023
North America was the dominant region in 2023
Ambiopharm Inc, Auspep, Bachem Holding AG, BCN Peptides, Chinese Peptide Company, CordenPharma, CPC Scientific, Creative Peptides, CSBio, Hybio Pharmaceutical, Peptide Institute, Inc., PolyPeptide Group, ScinoPharm, and Senn Chemicals AG
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Peptide Therapeutics Contract API Manufacturing Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Peptide Therapeutics Contract API Manufacturing Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Peptide Therapeutics Contract API Manufacturing Market Analysis and Forecast, by Scale of Operation
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Scale of Operation, 2020-2034
6.3.1. Preclinical/Clinical
6.3.2. Commercial
6.4. Market Attractiveness Analysis, by Scale of Operation
7. Global Peptide Therapeutics Contract API Manufacturing Market Analysis and Forecast, by Type of Synthesis Method Used
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Type of Synthesis Method Used, 2020-2034
7.3.1. Non-chemical Synthesis Method
7.3.2. Chemical Synthesis Method
7.4. Market Attractiveness Analysis, by Type of Synthesis Method Used
8. Global Peptide Therapeutics Contract API Manufacturing Market Analysis and Forecast, by Enterprise Type
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Enterprise Type, 2020-2034
8.3.1. Large Enterprise
8.3.2. Small and Medium Enterprise
8.4. Market Attractiveness Analysis, by Enterprise Type
9. Global Peptide Therapeutics Contract API Manufacturing Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Peptide Therapeutics Contract API Manufacturing Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Scale of Operation, 2020-2034
10.3.1. Preclinical/Clinical
10.3.2. Commercial
10.4. Market Value Forecast, by Type of Synthesis Method Used, 2020-2034
10.4.1. Non-chemical Synthesis Method
10.4.2. Chemical Synthesis Method
10.5. Market Value Forecast, by Enterprise Type, 2020-2034
10.5.1. Large Enterprise
10.5.2. Small and Medium Enterprise
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Scale of Operation
10.7.2. By Type of Synthesis Method Used
10.7.3. By Enterprise Type
10.7.4. By Country
11. Europe Peptide Therapeutics Contract API Manufacturing Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Scale of Operation, 2020-2034
11.3.1. Preclinical/Clinical
11.3.2. Commercial
11.4. Market Value Forecast, by Type of Synthesis Method Used, 2020-2034
11.4.1. Non-chemical Synthesis Method
11.4.2. Chemical Synthesis Method
11.5. Market Value Forecast, by Enterprise Type, 2020-2034
11.5.1. Large Enterprise
11.5.2. Small and Medium Enterprise
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Scale of Operation
11.7.2. By Type of Synthesis Method Used
11.7.3. By Enterprise Type
11.7.4. By Country/Sub-region
12. Asia Pacific Peptide Therapeutics Contract API Manufacturing Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Scale of Operation, 2020-2034
12.3.1. Preclinical/Clinical
12.3.2. Commercial
12.4. Market Value Forecast, by Type of Synthesis Method Used, 2020-2034
12.4.1. Non-chemical Synthesis Method
12.4.2. Chemical Synthesis Method
12.5. Market Value Forecast, by Enterprise Type, 2020-2034
12.5.1. Large Enterprise
12.5.2. Small and Medium Enterprise
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Scale of Operation
12.7.2. By Type of Synthesis Method Used
12.7.3. By Enterprise Type
12.7.4. By Country/Sub-region
13. Latin America Peptide Therapeutics Contract API Manufacturing Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Scale of Operation, 2020-2034
13.3.1. Preclinical/Clinical
13.3.2. Commercial
13.4. Market Value Forecast, by Type of Synthesis Method Used, 2020-2034
13.4.1. Non-chemical Synthesis Method
13.4.2. Chemical Synthesis Method
13.5. Market Value Forecast, by Enterprise Type, 2020-2034
13.5.1. Large Enterprise
13.5.2. Small and Medium Enterprise
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Scale of Operation
13.7.2. By Type of Synthesis Method Used
13.7.3. By Enterprise Type
13.7.4. By Country/Sub-region
14. Middle East & Africa Peptide Therapeutics Contract API Manufacturing Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Scale of Operation, 2020-2034
14.3.1. Preclinical/Clinical
14.3.2. Commercial
14.4. Market Value Forecast, by Type of Synthesis Method Used, 2020-2034
14.4.1. Non-chemical Synthesis Method
14.4.2. Chemical Synthesis Method
14.5. Market Value Forecast, by Enterprise Type, 2020-2034
14.5.1. Large Enterprise
14.5.2. Small and Medium Enterprise
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Scale of Operation
14.7.2. By Type of Synthesis Method Used
14.7.3. By Enterprise Type
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. Ambiopharm Inc
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Auspep
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Bachem Holding AG
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. BCN Peptides
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Chinese Peptide Company
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. CordenPharma
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. CPC Scientific
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Creative Peptides
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. CSBio
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Hybio Pharmaceutical
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
15.3.11. Peptide Institute, Inc.
15.3.11.1. Company Overview
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Financial Overview
15.3.11.5. Strategic Overview
15.3.12. PolyPeptide Group
15.3.12.1. Company Overview
15.3.12.2. Product Portfolio
15.3.12.3. SWOT Analysis
15.3.12.4. Financial Overview
15.3.12.5. Strategic Overview
15.3.13. ScinoPharm
15.3.13.1. Company Overview
15.3.13.2. Product Portfolio
15.3.13.3. SWOT Analysis
15.3.13.4. Financial Overview
15.3.13.5. Strategic Overview
15.3.14. Senn Chemicals AG
15.3.14.1. Company Overview
15.3.14.2. Product Portfolio
15.3.14.3. SWOT Analysis
15.3.14.4. Financial Overview
15.3.14.5. Strategic Overview
List of Tables
Table 01: Global Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Scale of Operation, 2020-2034
Table 02: Global Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Type of Synthesis Method Used, 2020-2034
Table 03: Global Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Enterprise Type, 2020-2034
Table 04: Global Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Region, 2020-2034
Table 05: North America Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Country, 2020-2034
Table 06: North America Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Scale of Operation, 2020-2034
Table 07: North America Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Type of Synthesis Method Used, 2020-2034
Table 08: North America Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Enterprise Type, 2020-2034
Table 09: Europe Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 10: Europe Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Scale of Operation, 2020-2034
Table 11: Europe Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Type of Synthesis Method Used, 2020-2034
Table 12: Europe Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Enterprise Type, 2020-2034
Table 13: Asia Pacific Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Asia Pacific Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Scale of Operation, 2020-2034
Table 15: Asia Pacific Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Type of Synthesis Method Used, 2020-2034
Table 16: Asia Pacific Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Enterprise Type, 2020-2034
Table 17: Latin America Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 18: Latin America Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Scale of Operation, 2020-2034
Table 19: Latin America Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Type of Synthesis Method Used, 2020-2034
Table 20: Latin America Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Enterprise Type, 2020-2034
Table 21: Middle East & Africa Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Middle East & Africa Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Scale of Operation, 2020-2034
Table 23: Middle East & Africa Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Type of Synthesis Method Used, 2020-2034
Table 24: Middle East & Africa Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast, by Enterprise Type, 2020-2034
List of Figures
Figure 01: Global Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) and Distribution (%), by Region, 2023 and 2034
Figure 02: Global Peptide Therapeutics Contract API Manufacturing Market Revenue (US$ Bn), by Scale of Operation, 2023
Figure 03: Global Peptide Therapeutics Contract API Manufacturing Market Value Share, by Scale of Operation, 2023
Figure 04: Global Peptide Therapeutics Contract API Manufacturing Market Revenue (US$ Bn), by Type of Synthesis Method Used, 2023
Figure 05: Global Peptide Therapeutics Contract API Manufacturing Market Value Share, by Type of Synthesis Method Used, 2023
Figure 06: Global Peptide Therapeutics Contract API Manufacturing Market Revenue (US$ Bn), by Enterprise Type, 2023
Figure 07: Global Peptide Therapeutics Contract API Manufacturing Market Value Share, by Enterprise Type, 2023
Figure 08: Global Peptide Therapeutics Contract API Manufacturing Market Value Share, by Region, 2023
Figure 09: Global Peptide Therapeutics Contract API Manufacturing Market Value (US$ Bn) Forecast, 2020-2034
Figure 10: Global Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Scale of Operation, 2023 and 2034
Figure 11: Global Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Region, 2024-2034
Figure 12: Global Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Type of Synthesis Method Used, 2023 and 2034
Figure 13: Global Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Type of Synthesis Method Used, 2024-2034
Figure 14: Global Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Enterprise Type, 2023 and 2034
Figure 15: Global Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Enterprise Type, 2024-2034
Figure 16: Global Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Region, 2023 and 2034
Figure 17: Global Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Region, 2024-2034
Figure 18: North America Peptide Therapeutics Contract API Manufacturing Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 19: North America Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Country, 2024-2034
Figure 20: North America Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Country, 2023 and 2034
Figure 21: North America Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Scale of Operation, 2023 and 2034
Figure 22: North America Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Type of Synthesis Method Used, 2023 and 2034
Figure 23: North America Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Enterprise Type, 2023 and 2034
Figure 24: North America Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Region, 2024-2034
Figure 25: North America Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Type of Synthesis Method Used, 2024-2034
Figure 26: North America Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Enterprise Type, 2024-2034
Figure 27: Europe Peptide Therapeutics Contract API Manufacturing Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 28: Europe Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 29: Europe Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 30: Europe Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Scale of Operation, 2023 and 2034
Figure 31: Europe Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Type of Synthesis Method Used, 2023 and 2034
Figure 32: Europe Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Enterprise Type, 2023 and 2034
Figure 33: Europe Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Region, 2024-2034
Figure 34: Europe Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Type of Synthesis Method Used, 2024-2034
Figure 35: Europe Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Enterprise Type, 2024-2034
Figure 36: Asia Pacific Peptide Therapeutics Contract API Manufacturing Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 37: Asia Pacific Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 38: Asia Pacific Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 39: Asia Pacific Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Scale of Operation, 2023 and 2034
Figure 40: Asia Pacific Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Type of Synthesis Method Used, 2023 and 2034
Figure 41: Asia Pacific Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Enterprise Type, 2023 and 2034
Figure 42: Asia Pacific Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Region, 2024-2034
Figure 43: Asia Pacific Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Type of Synthesis Method Used, 2024-2034
Figure 44: Asia Pacific Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Enterprise Type, 2024-2034
Figure 45: Latin America Peptide Therapeutics Contract API Manufacturing Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 46: Latin America Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 47: Latin America Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 48: Latin America Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Scale of Operation, 2023 and 2034
Figure 49: Latin America Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Type of Synthesis Method Used, 2023 and 2034
Figure 50: Latin America Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Enterprise Type, 2023 and 2034
Figure 51: Latin America Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Region, 2024-2034
Figure 52: Latin America Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Type of Synthesis Method Used, 2024-2034
Figure 53: Latin America Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Enterprise Type, 2024-2034
Figure 54: Middle East & Africa Peptide Therapeutics Contract API Manufacturing Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 55: Middle East & Africa Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 56: Middle East & Africa Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 57: Middle East & Africa Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Scale of Operation, 2023 and 2034
Figure 58: Middle East & Africa Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Type of Synthesis Method Used, 2023 and 2034
Figure 59: Middle East & Africa Peptide Therapeutics Contract API Manufacturing Market Value Share Analysis, by Enterprise Type, 2023 and 2034
Figure 60: Middle East & Africa Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Region, 2024-2034
Figure 61: Middle East & Africa Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Type of Synthesis Method Used, 2024-2034
Figure 62: Middle East & Africa Peptide Therapeutics Contract API Manufacturing Market Attractiveness Analysis, by Enterprise Type, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Peptide Therapeutics Contract API Manufacturing Market
